Dendrite’s clinical database utilised for Obesity Research Biobank Syndicate registry
Dendrite Clinical Systems in pleased to announce its clinical database system has been selected to collect, record and analyse data from the Obesity Research Biobank Syndicate (ORBiS) Registry. ORBiS is a network of multidisciplinary professionals working towards a common goal: to gain novel insights into obesity and weight management, and help translate these findings into improved patient care.
Led by University College London Centre for Obesity Research, this web-based registry aims to provide a comprehensive collection of high-quality patient data linked to biological samples to facilitate basic, clinical and translational research.
Patients under the care of specialist weight management services may be recruited, including those undergoing bariatric surgery and/or non-surgical weight loss interventions. With informed consent, clinical and research teams can upload data on individual patients to contribute to multicentre research.
Led by Professor Rachel Batterham and Miss Roxanna Zakeri, the ORBiS registry is supported by the National Institute for Health Research, University College Hospital NIHR Biomedical Research Centre and Sir Jules Thorn Charitable Trust.
“Obesity is one of the most serious chronic conditions facing the NHS and its associated co-morbidities – such as type 2 diabetes and cancer – are known to increase mortality and decrease patients’ quality of life,” said Dr Peter Walton, Dendrite Clinical Systems. “We look forward to working with the ORBIS collaborators to help them gain further insights and improve our understanding into the biomedical processes of obesity.”
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


